Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer
Sym015 shows superior specificity compared to TKIs for NSCLC
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic
Perioperative use of NSAIDs reduces risk of early relapse in breast cancer
COVID-19: Risk of millions relapsing back to smoking
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19
The COVID-19 and Cancer Consortium
COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19
Economic and research benefits of the AORTIC meeting
Meet the Expert: Prof Ifeoma Okoye
Conducting Oncology Clinical Trials in Africa II: Developing direction for the management of clinical trials in Africa